29.01.2013

Opening of the 11th CROMA subsidiary

CROMA-PHARMA is pleased to announce the opening of the 11th subsidiary in the Netherlands. With a population of 16,7 million people the Netherlands offer a high potential for future growth of CROMA-PHARMA. Prosperous conditions are being offered in all business areas Ophthalmology, Aesthetics and Orthopaedics. An experienced management has joined us which will strengthen CROMA-PHARMA's position in the European market place.
 
Management Board:

Andreas Leeb - based in Korneuburg, Austria
Walter van de Ven - based in Geldermalsen, Netherlands
Erwin de Kruif - based in Geldermalsen, Netherlands

22.01.2013

Bausch + Lomb and CROMA Donate Urgently-Needed Eye Drops

Product Will Benefit 25,000 People in Africa via LIGHT FOR THE WORLD.

An estimated 16 million people suffer blindness as a resulted of cataracts, making it the leading cause of blindness globally.  Cataract is the clouding of the human eye´s crystalline lens. This is despite cataract surgery being one of the most common surgical procedures worldwide.  For many, poverty makes accessing even basic eye care impossible. The Austrian organization LIGHT FOR THE WORLD supports people who have no access to ophthalmic care. Through cataract surgeries performed in 145 different projects in Africa, Asia, Latin America and Southeast Europe, LIGHT FOR THE WORLD saved the sight of 41,369 people in 2011.
 

Bausch + Lomb, the global eye health company, and CROMA, a private global specialty pharmaceutical and surgical company, have donated 50,000 eye drops (bromfenac sodium sesquihydrate), a highly effective, non-steroidal anti-inflammatory drug (NSAID) for postoperative ocular inflammation following cataract extraction, to LIGHT FOR THE WORLD’s projects in Africa. These eye drops, are vital for post-operative -treatment of cataract patients.

“This generous donation is remarkable and will have a huge impact on our projects!” states Dr. Karl Rigal, Chief Resident Ophthalmologist at the Vienna Hanusch-Hospital and voluntary board member of LIGHT FOR THE WORLD.  “The eye drops work well.  As they only have to be used twice a day, this makes the after-treatment in countries where medical care hardly exists, much easier. This is of real benefit to patients in developing countries who often are not used to taking medicine at all.”

Cataract surgery takes 15 minutes and in a developing country costs on average around €30. The surgery can restore sight even when someone has been blind from cataract for many years. However, without proper care after the cataract surgery, complications can develop leading to diminished vision or even loss of sight.

”It is our social responsibility and commitment to support the improvement of vision in economically challenged regions of the world, said Mag. Gerhard Prinz, CEO of CROMA Pharma GmbH. “CROMA has been contributing to LIGHT FOR THE WORLD for many years and we are proud to make a difference in improving health and quality of life.” 

“We are delighted to be able to support LIGHT THE WORLD in their effort to improve the sight of people in Africa,” said Calvin Roberts, M.D., executive vice president and chief medical officer, Bausch + Lomb. “Proper post-operative care is the key to maximizing the surgery’s results – ultimately achieving the best possible outcome for the patient.” 

 

 

22.11.2012

Mountaineer Geri Winkler and SYNOTABS® – partners for healthy joints

Geri Winkler becomes SYNOTABS® ambassador for CROMA

Vienna, 21 November 2012 – The well-known Austrian extreme mountaineer and adventurer Geri Winkler will act as ambassador and advertiser for the dietary supplement SYNOTABS® from CROMA. Geri Winkler relies on the joint support and protection offered by SYNOTABS® even on his extreme tours.

Geri Winkler made headlines for the first time in 1987 when he became the first diabetic to successfully complete a marathon. Since then Geri has completed many expeditions and adventure trekking tours in every part of the world, demonstrating that these sorts of tours and travel are also possible for diabetics.

Seven Summits and nEVEREST 9000+
One of the high points in Geri’s long list of successes was completing the climbs that made up the Seven Summits: Between 2001 and 2008 Geri Winkler climbed the highest peak on every continent.

Geri received particular attention with the project nEVEREST 9000+: Between October 2005 and June 2006 Geri conquered the largest climb possible on our planet from the lowest point on the earth, the Dead Sea in Jordan, to the peak of Mount Everest, which he reached as the first climber on 20 May 2006 via the south route. The only other climbers to conquer this maximum ascent apart from Geri Winkler were three members of a British expedition. Geri is the first diabetic in the world and also the first person from Vienna on the peak of Mount Everest.

Dietary supplement to protect and strengthen the joints
SYNOTABS®, the dietary supplement for healthy joints from CROMA, was Geri’s constant companion on his tours. Geri says, ‘On my tours and expeditions, my joints are placed under incredible strain. I can say that, based on my own experiences, the dietary supplement SYNOTABS® containing glucosamine and chondroitin sulphate helped to support my cartilage and to protect my joints. That’s why I am pleased about the professional partnership with CROMA.’

CROMA Managing Director Andreas Prinz: ‘We are very happy to have found in Geri Winkler a person who can authentically speak for SYNOTABS® based on his own experiences.

Downloads:
PR-Fotos Geri Winkler

Fotos: © Gerald Pfeisinger/ Philipp Vavra

 

22.06.2012

CROMA Award 2012 for Outstanding Scientific Work goes to Dr. Ewald Lindner

During the 53rd anual convention of the ÖOG (Austrian Ophthalmic Society) Dr. Ewald Lindner was distinguished with the CROMA Award 2012 for outstanding scientific work. The prize amounting to 3500 Euro was awarded for the research work „IL2RA Gene Polymorphism rs2104286 A>G Seen in Multiple Sclerosis Is Associated with Intermediate Uveitis: Possible Parallel Pathways?“

 

Foto: © Medical-Network

 

04.06.2012

CROMA is honoured as best family owned company

During a Gala in the Wiener Kursalon on May 23rd 2012, CROMA was distinguished with the award for "Best Family owned Company of Lower Austria", Austria's largest state.

The prize was awarded by business magazine WirtschaftsBlatt together with Bankhaus Spängler, BDO Austria and Österreichische Notariatskammer (Austrian Chamber of Civil Law Notaries).

The business paper's award goes to companies that "are characterized by courage, responsible acting towards employees and the region as well as by successful sustainable business" (WirtschaftsBlatt).

Foto: © WirtschaftsBlatt/Mayr

 

20.02.2012

Submission for the CROMA Award 2012 for outstanding scientific work

In 2012 CROMA will once more be awarding a prize for outstanding scientific work in the field of ophthalmology. The CROMA Research Promotion Award is endowed with 3.500,-- euros and is awarded by a jury of the Austrian ophthalmological society.

Submission criteria:
All the scientific work, the either not yet or have been published in the last two years can be submitted.

Deadline:
15th March 2012

More information here (german version)

 

27.01.2012

Scholarship for young ophtalmologists in Austria

In 2012 we invite five young ophthalmologists in training to major international congresses. The CROMA scholarships are endowed with an amount of up to 2.000 Euros and will enable ophthalmologists in training to attend international congresses.

 

The selection of grantees by CROMA takes place in close collaboration with a scientific advisory board: Prof. Dr. Binder (Chairman of the Department of Ophthalmology in the Rudolf Foundation, Ludwig Boltzmann Institute for Retinology and biomicroscopic laser surgery) and Prof. Dr. Oliver Findl (Board member of the Eye Department at Hanusch Hospital Vienna and Chairman of the Young Ophthalmoligist programs ESCRS).

More information about the scholarship for Austrian ophthalmologists available here (german version).

 

09.01.2012

Qube – Designed for Efficiency

CROMA and RUCK TMED presented the smart evolution in cataract surgery at the ESCRS in Vienna. The unveiling ceremony started on Sunday, 18th September, at 12:00 noon at the CROMA booth. After a countdown at the LED wall CROMA owner and founder Mag. pharm. Gerhard Prinz and Michael Ruck, Managing Director of RUCK TMED, introduced the new cataract system to the audience.

Qube was designed for efficiency and is an innovative and effective solution for anterior surgeons. Its state of the art design and visceral user interface was perfected for the use in clinical environments. In order to satisfy the market needs of the future Qube focuses on the areas of usability, user friendliness, reliability, serviceability and state of the art ergonomic design for the housing, the disposables and the User Interface.

The one-hand cassette system impresses with economical efficiency and premium quality. Exceptional safety is guaranteed through perfect anterior chamber stability. The systems required functions are controllable through the multifunctional footswitch. Qube will be available soon.

More information is available here.

  

09.01.2012

The CROMA ACADEMY - the first centre for education in Aesthetic Medicine in Austria is open now!

We at CROMA think that it is our duty to share our knowledge and achievements with others. That’s why we founded a place for educating doctors from different countries and different fields of expertise.

Seated in the beautiful 7th district of Vienna, the Academy will hold educational classes for the aesthetics and orthopedics divisions of CROMA.

Doctors from all over the world will be invited to join special lectures from leading experts where they will learn about the newest methods and injection techniques in the field of Aesthetic Medicine. In addition there will be special training and master courses for B&B partners.